REiNS collaboration seeks common outcome measures for neurofibromatosis clinical trials

(Wolters Kluwer Health) As potentially effective new treatments for neurofibromatosis (NF) are developed, standardized research approaches -- including outcome measures specific to NF -- are needed. The first report from the Response Evaluation in Neurofibromatosis and Schwannomatosis (REiNS) International Collaboration has been published as a supplement to Neurology®, the Official Journal of the American Academy of Neurology. The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health.
Source: EurekAlert! - Medicine and Health - Category: Global & Universal Source Type: news